Published in Br Med J on August 10, 1968
Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14
Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol (1989) 1.84
A rethinking on the benefits and drawbacks of common antioxidants and a proposal to look for the antioxidants in allium products as ideal agents: a review. Indian J Clin Biochem (2011) 0.76
Disseminated intravascular coagulation induced by progesterone in the pregnant rat. Prevention by estogens. Am J Pathol (1977) 0.75
Reading for Pleasure: Arbitrament of swords. Br Med J (Clin Res Ed) (1982) 0.75
Onions and blood fibrinolysis. Br Med J (1970) 0.75
Fresh onions and blood fibrinolysis. Br Med J (1969) 0.75
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease. Lancet (1967) 2.02
Rapid estimation of plasma fibrinogen concentration and its use as a guide to therapy of intravascular defibrination. Am J Obstet Gynecol (1952) 1.88
Determination of fibrinolytic activity of whole blood. With special reference to the effects of exercise and fat feeding. Lancet (1959) 1.50
The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J Clin Invest (1955) 1.47
Studies on the inhibition of fibrinolysis by lipids. Lancet (1957) 1.37
Effect of strenuous and graded exercise on fibrinolytic activity. Lancet (1967) 1.21
Occurrence of fibrinolytic activity following administration of incotinic acid. Proc Soc Exp Biol Med (1959) 1.18
The biochemistry and physiology of urokinase. Am J Cardiol (1960) 1.18
Fasting and non-fasting fibrinolytic activity. Lab Pract (1967) 0.95
Age and disease-related alterations in fibrinogen-euglobulin (fibrinolytic) behavior. Am J Med Sci (1966) 0.93
Recent trends in antifibrinolytic therapy. Br J Clin Pract (1967) 0.84
Recent trends in fibrinolytic therapy. Br J Clin Pract (1966) 0.84
Increased fibrinolytic activity in venous blood of hemiplegic limbs. Br Med J (1967) 0.84
A study of the possible effects of drugs on fibrinolytic activity in vitro. Lab Pract (1967) 0.84
Manipulation in treatment of low back pain: a multicentre study. Br Med J (1975) 6.20
Day-case surgery for hernias and haemorrhoids. A clinical, social, and economic evaluation. Lancet (1977) 4.01
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
Nurses and nursing in primary medical care in England. Br Med J (1976) 2.73
A year's experience with a mobile coronary resuscitation unit. Br Med J (1969) 2.49
Treatment of Behcet's syndrome with phenformin and ethyloestrenol. Lancet (1969) 2.28
Circumstances attending 100 sudden deaths from coronary artery disease with coroner's necropsies. Br Heart J (1975) 1.96
An epidemic of mussel poisoning in North-East England. Lancet (1968) 1.79
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials. Br Med J (1971) 1.78
The social and occupational characteristics of attached and employed nurses general practice. J R Coll Gen Pract (1980) 1.75
A comparison of the activities and opinions of attached and employed nurses in general practice. J R Coll Gen Pract (1980) 1.64
Estimation of euglobulin lysis time using a time-saving recorder. Lab Pract (1969) 1.48
Role of the kidney in fibrinolytic activity of blood. Lancet (1968) 1.46
Unsuspected exposure to asbestos and bronchogenic carcinoma. Br Med J (1977) 1.45
The role of the lung in blood fibrinolysis. Clin Sci (1969) 1.45
Study on the effects of tablet colour in the treatment of anxiety states. Br Med J (1970) 1.40
Effect of strenuous and graded exercise on fibrinolytic activity. Lancet (1967) 1.21
Fibrinolysis in pre-eclamptic toxaemia of pregnancy. Br Med J (1969) 1.18
Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. Br J Dermatol (1969) 1.17
Phenindione sensitivity complicating anticoagulant therapy. J Indian Med Assoc (1966) 1.10
The accuracy of estimating neck movements. Ann Phys Med (1965) 1.10
Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism. Surgery (1987) 1.08
Assay of gastrin by means of its gastric acid stimulating activity. J Physiol (1968) 1.03
Complications of inflammatory diseases of the sinuses. Otolaryngol Clin North Am (1993) 1.02
Problems in estimating the demand for hospital beds. J Chronic Dis (1964) 1.00
Marriage, pregnancy and multiple sclerosis. Brain (1966) 0.97
A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives. J Obstet Gynaecol Br Commonw (1970) 0.97
Phenformin and stanozolol in blood fibrinolytic activity. Br Med J (1970) 0.97
A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. J Cardiovasc Pharmacol (1986) 0.97
Fasting and non-fasting fibrinolytic activity. Lab Pract (1967) 0.95
Trial of clofibrate. Br Med J (1972) 0.93
Fibrinolytic activity in the blood of 99 healthy young British, African and Asian subjects. Lab Pract (1968) 0.92
Effect of atromid-S on fibrinolytic activity in patients with ischaemic heart disease and normal blood cholesterol levels. Br Med J (1966) 0.90
Fibrinolytic activity in the blood of Nigerian students after four years' residence in the United Kingdom. Lab Pract (1967) 0.90
The diagnosis of hypopituitarism with special reference to the estimation of plasma non-esterified fatty acids. J Endocrinol (1970) 0.90
Recurrent monocular blindness. Lancet (1968) 0.89
A study of possible causes of increased fibrinolytic activity during exercise. Thromb Diath Haemorrh (1969) 0.89
The association between cutaneous vasculitis and decreased blood fibrinolytic activity. Br J Dermatol (1971) 0.89
The identification of annual peak periods for a disease. Biometrics (1965) 0.87
Safety of coronary arterial prostacyclin infusion. Lancet (1981) 0.87
Study of proteins and fibrinolysis in patients with glomerulonephritis. Br Med J (1970) 0.85
Fibrinolytic activity of venous blood of patients with multiple sclerosis. Neurology (1969) 0.85
Comparison of fibrinolytic activity in hepatic and systemic venous blood. J Atheroscler Res (1968) 0.84
Controlled trial of the effect of cycloalliin on the fibrinolytic activity of venous blood. Atherosclerosis (1977) 0.84
Recent trends in antifibrinolytic therapy. Br J Clin Pract (1967) 0.84
Muscles as a possible source of plasminogen activators to the circulation. J Assoc Physicians India (1969) 0.84
Recent trends in fibrinolytic therapy. Br J Clin Pract (1966) 0.84
A study of the possible effects of drugs on fibrinolytic activity in vitro. Lab Pract (1967) 0.84
Increased fibrinolytic activity in venous blood of hemiplegic limbs. Br Med J (1967) 0.84
Double-blind controlled trial of a micronized preparation of flumedroxone (Demigran) in prophylaxis of migraine. Br Med J (1968) 0.83
Prevalence, aetiology and treatment of pain in the neck and arm. Trans Soc Occup Med (1967) 0.82
Failure to confirm a vascular cause of muscular dystrophy. Arch Neurol (1975) 0.81
Syncopal attacks in hypothyroid state. J Indian Med Assoc (1967) 0.81
The lymphatic system as contributor of plasminogen activator to the blood. Angiologica (1970) 0.81
Pulmonary artery thrombosis and the nephrotic syndrome. Br Med J (1967) 0.81
The uterus as contributor of plasminogen activator to the blood. J Obstet Gynaecol Br Commonw (1970) 0.81
The brain as contributor of plasminogen activator to the blood. Clin Sci (1970) 0.80
Posterior internal auditory canal closure following the retrosigmoid approach to the cerebellopontine angle. Am J Otol (1993) 0.80
A double-blind trial of bromelains as an adjunct to vaginal plastic repair operations. J Obstet Gynaecol Br Commonw (1970) 0.80
Fibrinolytic therapy in bacterial endocarditis: experimental studies in dogs. Eur Heart J (1986) 0.79
Fibrinolytic therapy in subacute bacterial endocarditis: an experimental study. Cardiovasc Res (1980) 0.79
Pentaerythritol tetranitrate (sustained action) in acute myocardial infarction. Br Heart J (1970) 0.79
A study of embolism in mitral valve disease and atrial fibrillation. Br Heart J (1983) 0.78
Effect of sulphinpyrazone on the development of experimental endocardial vegetations. Cardiovasc Res (1982) 0.78
Smoking and multiple sclerosis. Neurology (1966) 0.78
Fibrinolysis in pulmonary hypertension. J Atheroscler Res (1967) 0.78
Side-effects of phenindione. Br Med J (1968) 0.77
Fibrinolysis in renal disease. Br Med J (1969) 0.77
beta-thromboglobulin in antecubital vein blood--the influence of age, sex and blood group. Thromb Haemost (1979) 0.77
Tetranicotinoylfructose in disorders of digital blood flow. Practitioner (1971) 0.76
Partial identification of the fibrinolytic activators in onion. Atherosclerosis (1975) 0.76
Aspirin and blood fibrinolysis. Lancet (1970) 0.76
Fresh onions and blood fibrinolysis. Br Med J (1969) 0.75
Fibrinolytic activity in pregnancy. Br Med J (1970) 0.75
Fibrin degradation products and menstruation. Br Med J (1970) 0.75
Controlled trial of demigran in the prophylaxis of migraine. Br Med J (1967) 0.75
Proteins and fibrinolysis in recipients of renal allografts. J Clin Pathol (1971) 0.75
Metformin and stanozolol in blood fibrinolytic activity. Br Med J (1971) 0.75
Myocardium as contributor of plasminogen activator to blood. Br Heart J (1971) 0.75
The effect of exercise and heart rate on fibrinolytic activity. Blood Coagul Fibrinolysis (1993) 0.75
Thrombolytic therapy in coronary thrombosis. J Clin Pathol (1969) 0.75
Onions and blood fibrinolysis. Br Med J (1970) 0.75
Fibrinolytic activity and oral contraception. Br Med J (1970) 0.75